Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
February 11 2021 - 8:22AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February, 2021
Commission file number: 001-37891
AC IMMUNE SA
(Exact Name of Registrant as Specified in
Its Charter)
|
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
|
|
(Address of Principal Executive Offices)
|
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
AC IMMUNE SA
|
|
|
|
|
|
By:
|
/s/ Andrea Pfeifer
|
|
|
Name: Andrea Pfeifer
|
|
|
Title: Chief Executive Officer
|
|
By:
|
/s/ Joerg Hornstein
|
|
|
Name: Joerg Hornstein
|
|
|
Title: Chief Financial Officer
|
EXHIBIT INDEX
Exhibit
Number
|
Description
|
99.1
|
Press Release dated February 11, 2021
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Aug 2024 to Sep 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Sep 2023 to Sep 2024